Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Coating of human decay accelerating factor (hDAF) onto medical devices to improve biocompatibility.

Watkins NJ, Braidley P, Bray CJ, Savill CM, White DJ.

Immunopharmacology. 1997 Dec;38(1-2):111-8.

PMID:
9476122
2.

Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis.

Londei M, Savill CM, Verhoef A, Brennan F, Leech ZA, Duance V, Maini RN, Feldmann M.

Proc Natl Acad Sci U S A. 1989 Jan;86(2):636-40.

3.

A minority of patients with rheumatoid arthritis show a dominant rearrangement of T-cell receptor beta chain genes in synovial lymphocytes.

Savill CM, Delves PJ, Kioussis D, Walker P, Lydyard PM, Colaco B, Shipley M, Roitt IM.

Scand J Immunol. 1987 Jun;25(6):629-35.

PMID:
2955515
4.
5.

The interaction of fibronectin fragments with cultured cells and isolated nuclei.

Savill CM, Ayad SR.

Anticancer Res. 1986 Mar-Apr;6(2):315-9.

PMID:
3707068

Supplemental Content

Loading ...
Support Center